Arcturus Therapeutics Holdings Inc. (ARCT)
$12.61-8.22%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $358M
- Beta
- 2.48
- P/E (TTM)
- -3.90
- Short % float
- 20.56%
- Days to cover
- 5.9
- SI change
- -1.6%
- 1W
- -13.98%
- 1M
- -14.39%
- vs SPY 1W
- -14.41%
- vs SPY 1M
- -16.45%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on ARCT?
- LOPJLB’s latest quantitative signal on Arcturus Therapeutics Holdings Inc. (ARCT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ARCT in?
- Arcturus Therapeutics Holdings Inc. (ARCT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Arcturus Therapeutics Holdings Inc. (ARCT) do?
- Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lun…